Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Induces Dry Skin via Decreased in Aquaporin-3 Expression

An adverse reaction of dry skin occurs frequently during treatment with anticancer epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). In this study, we conducted basic research to clarify the mechanism of EGFR-TKI-induced dry skin and propose new treatments or preventative meas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikarashi, Nobutomo, Kaneko, Miho, Watanabe, Tomofumi, Kon, Risako, Yoshino, Makana, Yokoyama, Takatoshi, Tanaka, Riho, Takayama, Naoya, Sakai, Hiroyasu, Kamei, Junzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225942/
https://www.ncbi.nlm.nih.gov/pubmed/32260143
http://dx.doi.org/10.3390/biom10040545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225942/
https://www.ncbi.nlm.nih.gov/pubmed/32260143
http://dx.doi.org/10.3390/biom10040545

Ejemplares similares